NCT00643136View on ClinicalTrials.gov

A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

June 30, 2004

Conditions
Sleep DeprivationEpilepsies, Partial
Interventions
DRUG

Pregabalin

Pregabalin capsules 75 mg twice daily on Days 1-4, then 150 mg twice daily on Days 5-28

DRUG

Placebo

Matching placebo capsules twice daily for 28 days

Trial Locations (2)

5591 VE

Pfizer Investigational Site, Heeze

2501 CK

Pfizer Investigational Site, The Hague

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00643136 - A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures | Biotech Hunter | Biotech Hunter